Viewing Study NCT06552234

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2026-01-24 @ 5:23 PM
Study NCT ID: NCT06552234
Status: RECRUITING
Last Update Posted: 2025-11-20
First Post: 2024-08-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Efficacy Study of Repotrectinib in Frail and/or Elderly Patients With ROS1-rearranged Advanced NSCLC
Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC Stage IV View
None NSCLC, Stage III View
Keywords:

Keywords

Keyword Brief Keyword Text View
None tyrosine-kinase inhibitors View
None Frail patients View
None Elderly patients View
None ROS1 rearrangements View
None resistance View